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ABSTRACT

Legitimate and illegitimate use of lysergic acid diethylanide (LSD)
increased dramatically in the 1960 1 s.

Since then, a number of studies

have shown that LSD induces -psychotic symptoms in the user, suggesting a
possible correlation between exposure to LSD and certain psychoses.
This hypothesis is supported by repeated observations that LSD inhibits
5-HT systems in the brain and that central 5-HT systems may be implicated
in certain psychoses.

The present study was designed to test the hypoth-

esis that chronic administration of LSD to rats has an observable effect
on 5-HT neuronal functioning in the brain.

Rats were exposed to varying

doses of LSD, and sacrificed 1 or 14 days after the last dose.

Altera-

tion in the 5-HT system was estimated by measurement of turnover of 5-HT,
synaptosomal uptake of (3H)5-HT, and the extent of (3H)5-HT and (3H)spiroperidol binding.

The results do not support the hypothesis.

Chronic

LSD administration had no effect on 5-HT turnover, uptake, or receptor
binding.

In light of these results, the possibility exists that LSD

induces a psychotic effect in humans by other mechanisms.

The possibility

also exists that the effect in humans is not paralleled in rats.
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INTRODUCTION
Since the accidental discovery by Hofmann of the intense hallucinatory effect of

d~lysergic

acid diethylamide (LSD) in 1943, this drug has

been among the most noteworthy in modern times.

As one of the most

potent hallucinogens known to man, LSD has been the basis of an immense
body of published I iterature.

LSD has been employed for a variety of

legitimate purposes, including use by psychiatrists for the treatment of
patients with neurotic disorders (Chandler and Hartman, 1960; Ling and
Buckman, 1963; and Levine and Ludwig, 1964).
The subjective effects of LSD have been characterized as consisting
of impairments of sensory perception and thought processes.
11

The term

illucinogenic 11 has been coined for use in association with LSD, since

the drug is described as altering reality rather than producing hallucination (Sankar, 1975) in the mind of the user.
111 icit use of LSD has become popular since the drug appeared in
the 1960 1 s.

However, numerous accounts have been recorded by psychia-

trists describing patients who have experienced psychotic episodes persisting or beginning weeks or even months after their last exposure to
the drug.

For example, Elkes (1963) described delayed reactions to LSD

such as changes in mood, perceptual distortions, depersonalization, and
confusion.

Other discussions of psychoses presumably induced by LSD

include Cohen (1960), Fink, Simeon, Hawe, and ltil (1966), and Ungerleider,
Fisher and Fuller (1966).
The psychotic symptoms have been characterized in the DSM-I I I. 1981,
as comprising two syndromes.

These are an organic delusional syndrome
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and an organic affective syndrome.

The delusional syndrome consists of

delusions, or the belief in something not real, while the patient is in
a normal state of consciousness.
of mood instability.

The organic affective syndrome consists

Both of these disorders are associated with hallu-

cinations, paranoia and personality disintegration.

Another psychiatric

disorder arising from the use of LSD is the flashback phenomenon .

Flash-

backs are repetitions of hallucinatory perceptions occurring weeks or
months after the effect of the drug has worn off.

This phenomenon is

described by Welpton (1968) and Horowitz (1969).
The biochemical basis of these LSD-induced psychotic effects has
been the object of a number of scientific inquiries.

It has been shown

that intravenously administered LSD has a half-1 ife in the human body of
approximately three hours (Aghajanian and Bing, 1964).
rapid elimination of the drug.

This suggests a

This, in association with the psychiatric

data, suggests that LSD may be causing some effect that persists after
i ts remova 1 .
A large amount of research has been carried out in an attempt to
elucidate the mechanism of action of LSD in the central nervous system.
Rosencrans et al (1967) showed that acute exposure to LSD caused rat
brain 5-HT to increase and level off after 90 minutes.

Aghajanian

~ ~

(1972), using microiontophoretic methods , administered LSD to the midbrain raphe nuclei.

This caused a potent inhibit ion of the rhythmic fir-

ing of the 5-HT neuronal cell bodies residing there.

Aghajanian

~~

(1982) measured intracellular recordings from the rat raphe which demonstrated inhibition of 5-HT neuronal firing by LSD .

It has been proposed

by some researchers (Diaz and Huttenan , 1972; Peters 1973) that this
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profound effect of LSD on 5-HT neurons could be the mechanism of LSDinduced psychotic manifestations.

Weight is added to this hypothesis

due to the extensive study of biogenic amines including 5-HT in schizophrenia and related psychotic disorders.

The biogenic amine hypothesis

intimately relates 5-HT with psychosis (Baldessarini

~ ~.

1972; Garver

and Davis, 1979).
Researchers have attempted to examine the effects of LSD on 5-HT
turnover VJith conflicting results.

Diaz and Huttenan (1972) administered

20 ug/kg LSD to rats orally on a daily basis for one month.
reported an increase in 5-HT in the whole brain preparation.

They
Other

research (Peters, 1973; Peters, 1976) reported a decrease in 5-HT turnover in the midbrain after administration of 20 ug/kg/day LSD for various
periods of time.

Peters (1974) reported an increase in 5-HT turnover

when 100 ug/kg/day was administered.
The doses and time periods chosen for the experiments carried out
in our study were decided upon based on this previously reported data.
Treatment conditions consisting of similar time periods but much larger
doses of LSD (10 times the ED 50 ) were utilized in order to insure the
occurrence of an effect if one was to be observed.
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MATERIALS AND METHODS
In recent years, a variety of biochemical methods have been developed with which researchers can study the activity of neurons and neurotransmitters.

Three biochemical parameters which can be utilized to

determine the integrity

of~

neurotransmitter system are neurotransmitter

turnover, uptake of radiolabeled neurotransmitter, and the binding of
radioligands to neurotransmitter receptors.
Turnover of a neurotransmitter refers to the renewal of the substance:

Certain

ass~mptions

should be met in order to measure the turn-

over of 5-HT in the brain (Neff~~. 1968).
summarized as follows:

These assumptions can be

(1) 5-HT enters the system by synthesis and is

lost by metabolism, (2) a steady state exists where the rate of formation
of 5-HT equals its degradation, (3) the turnover rate of 5-HT remains
consistent but not necessarily equal during experimentation, and (4) no
distinction is made between newly synthesized and old molecules of 5-HT.
Tozer et al (1966) and Neff and Tozer (1968) have evaluated the measurement of 5-HT turnover after pargyl ine administration.

The levels of 5-HT

continue to rise after inhibition of MAO until the rising levels of 5-HT
block the process (Millard et~. 1972; Baumann and Valdmeier, 1981).
This phenomenon has been called

11

end product inhibition 11 •

The method of measuring high-affinity synaptosomal uptake of radiolabeled neurotransmitters began with the development of methods which
allowed intact nerve endings to be pinched off and separated (Gray and
Whittaker, 1962).

It was later shown that these high-affinity uptake

mechanisms were sodium-dependent, ouabain-sensitive, and saturable
(Bogdanski~~. 1968).

Kuhar et al (1972) demonstrated that the uptake
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of (3H)5-HT in rat forebrain was carried out by 5-HT neurons.
ing the midbrain raphe, 5-HT uptake was selectively reduced.

By lesionThe para-

meters of this experimental methodology were worked out by Shaskan and
Snyder (1970).
by Kuhar (1973).

A general description of the methodology was published
More recently, high-affinity synaptosomal uptake has

been used to measure long-term effects of methylamphetamine on 5-HT
neurons in rat brain (Ricaurte

et~'

1980).

The most recently developed methodology utilized to detect alterations in neurotransmitter systems is radiol igand-receptor binding technique.

In rat brain preparations, (3H)5-HT has been shown to bind in a

saturable fashion and with regional variations consistent with the theorized location of the 5-HT postsyraptic receptor (Bennet and Snyder, 1975).
At the same time, other researchers came to similar conclusions using
membrane preparations (Fillion~~. 1975),

These results have since

been reproduced with a reasonable amount of consistency (Fill ion
1977; Peroutka~~' 1979).

et~.

Recent experimentation has also advanced

the hypothesis that there are subgroups of 5-HT receptors 0ith differing
binding capabilities for various radioligands.
In the rat cerebral cortex, two main subgroups of 5-HT receptors
have been hypothesized to exist.

One group of receptors has a high

affinity for (3H)5-HT, while the other group of receptors has a high
affinity for 3H-spiropridol and other 5-HT antagonists (Leysen and
Laduron, 1977; Quik ~~. 1978).

Spiroperidol is a butyrophenone

neuroleptic drug originally developed for clinical use but judged to be
unsuitable due to severe side effects.

In the cortex , (3H)5-HT and (3H)-

spiroperido1 have been shown to be displaceable by LSD, and (3H)-LSD has
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been shown to bind to the sites of both radial igands (Creese and Snyder,
1978; Peroutka and Snyder, 1979; and Seeman~~. 1980).

Both 5-HT and

spiroperidol have been shown to displace (3H)-LSD from cortical binding
sites (Peroutka and Snyder, 1979).

The high-affinity (3H)-spiroperidol

binding site has been hypothesized to be serotonergic due to the ability
of 5-HT antagonists such as LSD, cinanserin, and mianserin to displace
it from cortical binding sites, where it is most abundant (Peroutka and
Snyder, 1981).

This evidence combined suggests that 5-HT and spiroperi-

dol bind to separate subgroups of 5-HT receptors in the cerebral cortex
and that LSD binds to both.

Disagreement does exist, however, to the

hypothesis that (3H)-spiroperidol labels a 5-HT receptor (Middlemiss~
~,

1980).

It is interesting to note that this is due to conflicting

results, and not theoretical argument.
Although lesions of the midbrain raphe have been shown not to cause
adaptive changes in either of the two subgroups of receptors described
(Blackshear~~.

above

1981), chronic administration of tricyclic anti-

depressants has been shown to produce a decrease in the number of cerebral
~ortex

5-HT receptor binding sites (Segawa et~. 1979; Kellar~~.

1981; and

Maggi~~.

1981).

Alterations in (3H)-spiroperidol binding

have been found in rat striatum after chronic methylamphetamine administration (Akiyama~~. 1982). ·
The purpose of this project is to gain a deeper understanding of the
mechanism by which LSD acts on the 5-HT system in the cerebral cortex and
the rest of the brain.

We have attempted to identify and characterize

adaptive changes in the 5-HT system after chronic administration of high
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doses of LSD.

It is hypothesized that the LSD-induced psychoses diagnosed

by psychiatrists can be linked to altered functioning of the 5-HT system.
If this is so, then demonstration of induced biochemical adaption will
greatly enhance the understanding of the causes and effects of psychoses.
General Methods
All rats used in these experiments were male Long-Evans (Charles
River Breeding Laboratories, Waltham, Massachusetts) weighing between
200-250 grams at time of sacrifice.

All treatments of LSD to rats were

administered via the intraperitoneal route.
without anesthesia.

All rats were guillotined

Whole brains were rapidly removed over ice .

The

brains were dissected based on descriptions by Glowinski and Iversen
(1966) with modifications.
one stroke of a spatula.
the underlying tissue.

The cerebral hemispheres were separated with
The cortices were peeled back and stripped from

Cortices used in turnover studies were assayed

immediately after sacrifice.

Tissue used in uptake and binding studies

was stored at -7ooc until assay (less than four weeks).
Treatments for administration of LSD consisted of the same pair of
conditions for all three methods utilized.

Rats were treated with 1

mg/kg/day LSD for 14 consecutive days followed by one drug-free day prior
to sacrifice, or they were treated with 1 mg/kg/day LSD for 14 consecutive days followed by 14 drug-free days prior to sacrifice.

In the turn-

over studies, additional experiments were conducted using varying conditions.

These were an acute study of 100 ug/kg LSD at six hours prior to

sacrifice; seven consecutive days of treatment with 1 mg/kg/day LSD followed by 14 days without treatment prior to sacrifice, and 14 consecutive
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days of treatment with 0.5 mg/kg/day LSD followed by 14 drug-free days
prior to sacrifice.
In the turnover studies, rats were treated with the monamine oxidase
inhibitor, pargyline, 75 mg/kg i.p. at 0, 2, or 4 hours prior to sacrifice.

In the uptake studies, one grol!p of rats was given 75 ug of 5,6-

dihydroxytryptamine, a selective 5-HT .neurotoxin, two weeks prior to
sacrifice.

The 5,6-DHT was administered intracerebroventricularly as

described by Noble~~ (1967) with a few differences.

The stereotaxic

apparatus used in this study was provided by David Kopf Company, Tujunga,
California.
Turnover Studies
The method of Curzon and Green (1970) was used to measure 5-HT
fluorescence.

The determination of levels of 5-HT after pargyline was

accomp 1 i shed by measuring _the f 1uorescence of 5-HT bound to the fl uorescent marker compound, ortho-phthalaldehyde (OPT).
modified by Ciarlone (1976).

The method was slightly

Tissue was first weighed, then homogenized

in 10 volumes of acidified n-butanol using a polytron homogenizer at
speed 4 for 30 seconds.

Internal standards were used.

in 0.3 ml aliquots of 0. 1 N HCl to 3 ml of n-butanol.
dissolved in a similar volume of HCl.
g for five minutes.

These were added
The samples were

These were centrifuged at 1,000 x

Two and one-half ml of the supernatant was aspirated

and added to tubes containing 1 . 6 ml of 0. 1 N HCl and 5 ml of n-heptane.
These were vigorously shaken for five minutes.
then aspirated.
analysis.

The organic phase was

A 0.2 ml aliquot of the aqueous phase was removed for

Each sample was added to 1.2 ml of 4 mg% OPT and placed in a
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bath of boiling water for 10 minutes.
after removal.

The samples were allowed to cool

Fluorescence was read using an Aminco-Bowman spectrophoto

fluorometer at 355 excitation and 470 emission.

Values were expressed

in ug 5-HT/gram tissue wet weight.
Synaptosomal Uptake Studies
The assay procedure was modified from the method of Coyle and
Snyder (1979).

The frozen tissue was weighed and deposited in 10 volumes

of 0.32 M sucrose.

This was then homogenized using a motor-driven teflon

glass pestle with a clearance of 0.03 cm, at about 1,000 rpm.
and-down strokes were used in homogenization.
trifuged at 4°c at 700 x g for 10 minutes.

Ten up-

The homogenates were cen-

The pellet was then discarded.

The synaptosomal homogenate was divided into six aliquots of 0.2 ml each.
These were evenly divided among

o0 c

and 37°c incubations.

The 0.2 ml

synaptosomal homogenates were each added to 0.8 ml of incubation medium.
The medium contained:

NaCl (118.5 mM), KCl (4.8 mM), KH 2 P0 4 (1.2 mM),

MgSOi+ (1.2 mM), NaHC0 3 (24.8 mM), EDTA (0.13 mM), pargyline (10- 5 M),
ascorbate (0.2 mg/ml), d-glucose (1 mg/ml), and (3H)5-HT (10- 8 M) (20 Ci/
mM, New England Nuclear Corporation, Boston, Massachusetts).
was gassed for 15 minutes prior to use with 95% 0 2 :5% C02.

The mixture
The 37°c sam-

ples were incubated for six minutes, after which they were replaced in an
ice bath with the
for 60 minutes.

o0 c

samples.

All tubes were centrifuged at 1,000

The supernatant was aspirated and discarded.

xg

The pellet

was vortexed with 1 ml absolute ethanol and immediately rinsed with another
1 ml of absolute ethanol.

These were added to scintillation vials with

10 ml Econofluor (New England Nuclear Corporation).

Protein measurements
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were carried out using the method of Lowry~~ (1951).

Specific synap-

tosomal uptake of (3H)S-HT was calculated by subtracting the mean value
of the
tions.

o0 c

incubation samples from those obtained from the 37°c incuba-

Radioactivity was measured using a Packard Tri-Carb model 3335

1 iquid scintillation spectrometer.

Uptake was expressed as pM (3H)S-HT/

mg protein/six minutes.
Binding Assays
The tissue preparation and assay procedure was a modification of
the method of Peroutka and Snyder (1979).

The frozen tissue was weighed

and placed in 10 volumes of ice-cold 0.32 M sucrose.
ized using a motor-driven teflon-glass pestle.
and 10 up-and-down strokes were used.
trifuged at 700 x g for 10 minutes.

This was homogen-

The speed was 1,000 rpm

The resulting homogenate was cenThe pellet was discarded.

The

supernatant was removed and centrifuged at 50,000 x g for 10 minutes.
The resulting pellet was separated from the supernatant and incubated in
10 volumes of SO mM Tris buffer (pH 7.4 at 25°c) after resuspension.
After this incubation, the preparation was recentrifuged at 50,000 x g
for 10 minutes.

The supernatant was again discarded and the pellet was

resuspended in 10 volumes of Tris buffer (pH 7.4 at 25°c) with 1 mg/ml
abscorbate and 10- 5 M pargyline.

This preparation was incubated at 37°c

for 10 minutes and then frozen at -70°c until use (not more than four
weeks).
For assay, the tissue preparation was diluted to 80 volumes.

Incu-

bation tubes received 0.8 ml of tissue, 0. 1 ml of (3H)-ligand solution,
and 0. 1 ml of displacer or buffer.

Final tissue concentration was 10
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mg/ml.

The final concentrations of the (3H)-1 igands were 0.2 nM for

spiroperidol and 2.0 nM for 5-HT.

The tubes were incubated at 37°c for

10 minutes for 5-HT and 15

for spiroperidol.

minute~

The samples were

cooled in an ice bath for 15 minutes after incubation.

They were then

rapidly filtered through Whatman GF/B filters with three 5 ml rinses of
ice-cold 50 mM Tris buffer (pH 7.4 at 25°c).

The filters were heated

until dried and added to scintillation vials with 10 ml Econofluor.

The

samples were allowed to equilibrate overnight and counted the following
day in a Packard Tri-Carb model 3335 liquid scintillation spectrometer.
Specific binding of (3H)5-HT was defined to be the excess over blank in
the presence of 10- 5 M unlabeled 5-HT and that of (3H)-spiroperidol in
the presence of 10- 6 M unlabeled spiroperidol.

(3H)5-HT (26.3 Ci/mM)

and (3H)-spiroperidol (23.8 Ci/mM) were obtained from New England Nuclear
Corporation, Boston, Massachusetts .

Other reagents were obtained from

Sigma Chemical Company (St. Louis, Missouri).
Statistics
For turnover studies, differences in results were considered insignificant if the standard errors of the means overlapped.

In uptake

studies, the students' t-test was used to determine if differences
between the drug-treated and control conditions existed.

In binding

studies, I inear regression analysis was utilized to determine the best
fit on a straight line for the six points of the Scatchard plot.

The

students' t-test was used to determine whether or not the mean kd (dissociation constant, measured as the - inverse of the slope of the line)
or mean Bmax (maximum number of binding sites, measured as the

11

cept of the line) were different in treated and control groups.

x 11 inter-
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RESULTS
Effect of LSD on 5-HT Turnover
The effect of an acute dose of 100 ug/kg LSD is shown in figure 1.
The level of 5-HT at the time of sacrifice was increased from 0.7 ug/g
to 0.9 ug/g.

Also, turnover was inhibited at all time points.

Figure 2

shows the turnover curve for treatment with 1 mg/kg/day LSD for seven
consecutive days followed by a 14-day period without treatment.

Figure

3 denotes the effect of 0.5 mg/kg/day LSD administered daily for 14
consecutive days followed by 14 drug-free days.

The two-hour point of

figure 3 was found to show a difference between treated and control.
Figure 4 shows the effect of 1 mg/kg/day LSD for 14 consecutive days
followed by one day without treatment prior to sacrifice.

Figure 5

shows the effect of 1 mg/kg/day LSD for 14 consecutive days followed by
14 days without treatment prior to sacrifice.
Effect of 5,6-Dihydroxytryptamine .£.!:_LSD on (3H)5-HT Uptake
lntracerebral injection of 75 ug of 5,6-DHT dissolved in physiological saline was shown to reduce (3H)5-HT uptake in rat cerebral cortex
14 days after administration.
treated controls.

Uptake was diminished by 29% from sham-

The control value was 2.18 + 0.14, while the 5,6-DHT

treated value was 1.55::_0.19 (Table 1).

Administration of 1 mg/kg/day

LSD for 14 consecutive days followed by 1 or 14 days without treatment
prior to sacrifice caused no significant change between drug-treated or
control (3H)5-HT uptake in the rat cerebral cortex (Table 1).
expressed as picomoles (3H)5-HT/mg protein/six minutes.

Data is
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Effect of LSD on Affinity Constant and Maximum Number of Binding Sites
for (3H)5-HT Receptors~ Rat Cerebral Cortex
Table 2 shows the effects on rats of 1 mg/kg/day LSD for 14 consecutive days followed by one drug-free day prior to sacrifice (experiment
1).

The Kd value for control rats was 6.76 + 0.36 mM, while for LSD-

treated rats it was 6.92 + 0.60 nM.

The Bmax for the controls was 7.93
~

+ 0.42, while for the LSD-treated group it was 8.58

0.47 pM/g.

Exper-

iment 2 shows the effect of 1 mg/kg/day LSD for 14 consecutive days followed by 14 days of no treatment prior to sacrifice.
control was 6.81
+ 0.45 nM.

~

The Kd value for

0.66 nM, while for the LSD-treated group it was 6.32

The Bmax for the control group was 7.90 + 0.39 pM/g, while

for the LSD-treated group it was 7.37 + 0.49 pM/g.
Effect of LSD

~Affinity

for (3H)-Spiroperidol

Constant and Maximum Number of Binding Sites

Receptors~

Rat Cerebral Cortex

Table 3 shows the effects of 1 mg/kg/day LSD for 14 consecutive
days with one day without treatment prior to sacrifice (experiment 1).
The Kd value for control rats was 1.09 + 0.046, while for the LSD-treated
group it was 1. 12+0.150.

The Bmax for the control group was 4.15 +

0.26, while for the LSD-treated group it was 3.79 + 0.48.

Experiment 2

shows the effect of 1 mg/kg/day LSD for 14 consecutive days followed by
14 days of no treatment prior to sacrifice.

The Kd value for the con-

trol group was 1. 16 + 0.09, while for the LSD-treated group it was 1.10
+ 0.02.

The Bmax for the control group was 4.54

LSD-treated group it was 4.34 + 0.43.

.:!:_

0.54, while for the

Affinity constant data was

expressed in nanomoles (3H)-l igand and binding site data was expressed
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in picomoles (3H)-ligand/gram tissue wet weight.

Figure 6 shows a typi-

cal Scatchard plot based on the data of Table 2, experiment 2.
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Table 1.

A Comparison of the Effect of 5,6-Dihydroxytryptamine or LSD
on Synaptosomal Uptake of (3H)5-HT in Rat Cerebral Cortex

pM (3H)5-HT/mg
Protein/6 Min ±.. SEM

n
--

Experiment 1 :

o. 14

Control

2. 18 +

5,6-DHT, 75 ug

1. 55 + 0. 19

3
J:'•

Experiment 2:
Control

2.49 +

o. 19

3

LSD, 1 mg/kg/day,

2.26 + 0.25

3

Control

2.25 + 0.34

3

LSD, 1 mg/kg/day,

1.92 + 0.40

3

14 drug-free days
Experiment 3:

14 drug-free days

*

Represents statistical significance
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Table 2.

A Comparison of the Effect of LSD on the Affinity Constant and
Maximum Number of Binding Sites for (3H)5-HT in Rat Cerebral
Cortex

Kd (nM) ± SEM

Bmax (pM/g) ± SEM

n

Control

6.76 + 0.36

7.93 + 0.42

3

LSD, 1 mg/kg/day,

6.92 + 0.60

8.58 + 0.47

3

Control

6.81 + 0.66

7.90 + 0.39

5

LSD, 1 mg/kg/day,

6.32 + 0.45

7.37 + 0.49

5

Experiment 1 :

drug-free day
Experiment 2:

14 drug-free days
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Table 3.

A comparison of the Effectof LSD on the Affinity Constant and
Maximum Number of Binding Sites for (3H)-Spiroperidol in Rat
Cerebral Cortex

Kd (nM) ± SEM

Bmax · (pM/g) ± SEM

-n

Control

l.09 + .046

4.15 + 0.26

3

LSD, l mg/kg/day,

1. 12 + . 150

3.79 + 0.48

3

Control

1.16 + .085

4.52 + 0.54

3

LSD, 1 mg/kg/day,

1.10 + .020

4.34 + 0.43

3

Experiment l :

1 drug-free day
Experiment 2:

14· drug-free days
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LEGENDS TO FIGURES
Figure _l:

Rats were administered 100 ug/kg LSD i.p. six hours prior to
sacrifice.

Rats were sacrificed at 0, 2, and 4 hours after

treatment with 75 mg/kg pargyline.

All data points represent

the mean of a minimum of four determinations.
Figure 2:

Rats were administered LSD (1 mg/kg/day for seven days), followed by 14 days without treatment prior to sacrifice.

Rats

were administered 75 mg/kg pargyline at 0, 2, and 4 hours
prior to sacrifice.

All data points represent the mean of a

minimum of four determinations.
Figure 3:

Rats were administered .LSD (0.5 mg/kg/day for 14 days), followed by 14 days without treatment prior to sacrifice.
w~re

Rats

administered pargyl ine,. 75 _mg/.kg i .p., at 0, 2, and 4

hours prior to sacrifice.

All data points represent the mean

of a minimum of four determinations.
Figure 4:

Rats were administered LSD (1 mg/kg/day for 14 days), fol lowed
by one day without treatment prtor to sacrifice.

Rats were

administered pargyline, 75 mg/kg i.p., at 0, 2, and 4 hours
prior to sacrifice.
minimum of four

All data points represent the mean of a

determina~lons.
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Figure 5:

Rats were administered LSD (1 mg/kg/day for 14 days), followed
· by 14 days without treatment prior to sacrifice.

Rats were

administered 75 mg/kg pargyline i.p. at 0, 2, and 4 hours
p~ior

to sacrifice.

All data points represent the mean of a

minimum of six determinattons.
Figure 6:

Data is based on the- results of

th~ee

experiments.

X-axis - Picomoles (3H)-spiroperidol/g tissue wet weight.
Y-axis - Picomoles (3H)-spiroperidol/g tissue/nM (3H)-spiroper i do 1• .
Correla~ion

coefficient - 0.97.
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Figure.!_.

A COMPARISON OF SEROTONIN TURNOVER IN THE CEREBRAL CORTEX OF
RATS AFTER ACUTE LSD OR SALINE
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Page 2'J

Figure~-

A COMPARISON OF SEROTONIN TURN.OVER IN THE CEREBRAL CORTEX OF
RATS AFTER SEVEN CONSECUTIVE DAYS OF TREATMENT WITH LSD OR
SALINE. FOLLOWED BY FOURTEEN DAYS WITHOUT TREATMENT PRIOR TO
SACRIFICE
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Figure

1·-

A COMPARISON OF SEROTONIN TURNOVER IN THE CEREBRAL CORTEX OF
RATS AFTER- FOURTEEN CONSECUTIVE DAYS OF TREATMENT WITH LSD OR
SALIN~

FOLLOWED BY FOURTEEN DAYS. WITHOUT TREATMENT PRIOR TO

SACRI Fl CE.
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Figure!±.:

A COMPARISON OF SEROTONIN TURNOVER lN THE CEREBRAL CORTEX OF
RATS AFTER FOURTEEN CONSECUTIVE DAYS OF TREATMENT WITH LSD OR
SALINE FOLLOWED BY ONE DAY WITHOUT TREATMENT PRIOR TO SACRIFICE
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Figure

.2:

A

29.

COMPARISON OF SEROTONrn TURNOVER IN THE CEREBRAL CORTEX OF

RATS AFTER FOURTEEN CONSECUTIVE OAYS OF TREATMENT WITH LSD OR
SALINE FOLLOWED BY FOURTEEN DAYS WITHOUT TREATMENT PRIOR TO
SACRIFICE
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Figure~·

REPRESENTATIVE. SCATCHARD PLOT ANALYSIS OF THE DATA IN TABLE 3,
EXPERIMENT 2
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DI SC USS I ON.
This study has addressed the hypothesis that psychotic effects diagnosed as LSD-induced are due to adaptations or alterations of the functioning of 5-HT neurons in the CNS.

Acute administration of LSD produces

a significant elevation in5-HT levels accompanied by a complete cessation of turnover

(Rosecrans~~'

1967).

This pharmacologic effect is

assumed to be related to the human LSD experience due, in part, to the
information available on the patterns of innervation of 5-HT neurons.
Raphe nuclei B7 , B8 , and B9 send efferent fibers via the median forebrain
bundle to the amygdala, thalamus, hippocampus, and cortex (Dahlstrom et
~'

1964).

The fibers of these nuclei are present in the cortex samples

utilized for this study.
The results of acute and chronic LSD administration on 5-HT turnover
suggest that the drug exerts little persistent effect on biochemical parameters which assess function of 5-HT neurons.

Chronic administration of

even 10 times the acute LSD dose for 14 consecutive days resulted in no
significant alteration in levels or turnover of 5-HT after 1 or 14 days
without treatment.
of 5-HT turnover.

Acute LSD at 100 ug/_kg (f_igure 1) caused a cessation
When levels of 5-HT in cerebral cortex were measured

six hours after LSD, the treated rats showed no change in 5-HT levels
over the four hours after pargyline administration, while the control
rats showed the increase in 5-HT characteristic of all the stuqies.

This

suggests that the levels of 5-HT had risen to a ceiHng value and leveled
off due to end-product inhibition (inhibition of tryptophan-5-hydroxylase
by 5-HT).

Page 3~Although the 5-HT level at the two-hour time point of figure 3 is
significantly different from control, this result can be attributed to
experimental error.

This study was repeated identically with two times

the dose as shown in figure 5, and the results in this case showed no
difference from control.

Overall, the turnover data suggest that the

LSD exerts its effects on 5-HT neurons only when it is present in sufficient quantities in the CNS.

The possibility of a _residual effect on

turnover after LSD is eliminated seems, from this data, to be unlikely.
The synaptosomal uptake of (3H)5-HT was measured after administration of 5,6-dihydroxytryptamine, a specific 5-HT neurotoxin (Baldessarini
et~.

1973; Daily et 2..!,. 1973; and Baumgarten et.!!_, 1972).

The tri-

cyclic antidepressant, desipramine, was administered one hour prior to
the 5,6-0HT.

Since desipramine is a specific norepinephrine uptake

blocker, it has been used to improve the specificity of 5,6-DHT for 5-HT
neurons.

The 5,6-DHT was injected intracerebrally into the lateral ven-

tricle since it would have been rapidly metabolized and excluded from
the CNS if administered parenterally.
of (3H)5-HT by 29% (Tablet).

The 5,6-DHT diminished the uptake

Chronic treatment with LSD followed by 1

or 14 days without treatment produced no alteration in uptake of (3H)5-HT
in rat cortex (Table 1).

Rats given other drugs; for example, metamphet-

amine at 25 mg/kg/day for four days, exhibit impaired uptake of (3H)5-HT
even after 21 drug-free days (Ricaurte et.!!_, 1981).
Receptor binding experiments for both (3H)5-HT and (JH)-spiroperidol
were carried out in order to examine 5-HT receptors according to their
currently accepted order.

That is that the 5-HT receptor in the rat
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cerebral cortex is made up of two

subgroups~

One subgroup binds (3H)5-HT

and this is displaceable by unlabeled 5-HT with an ICso of approximately
10-7 M- (Creese and Snyder, 1978; Peroutka and Snyder, 1979).
gests a . high affini.ty of: this receptor for 5-HT.

This sug-

The other currently

accepted 5-HT receptor binds (3H)-spiroperidol and this is not easily
displaced by 5-HT, but is dJsplaceable by 5-HT antagonists such as
unlabeled spiroperidol, mianserin, or cinanserin

(Seeman~~'

1980;

Qui k et ~' 1978).
Receptor binding experiments for both (3H)5-HT and (3H)-spiroperidol
showed no significant changes in Kd or Bmax (Tables 2 and 3).

These two

parameters of receptor populations are frequently used to measure and
characterize specific neurotransmitter receptors.

Other researchers have

shown the Kd and Bmax of brain _receptor populations. to be adaptable to
prolonged exposure to certain dr_u gs.

Specifically for the 5-HT receptor,

Akiyama et!.!.. (1982) showed changes in Bmax of (3H)-spiroperidol binding
after 14 days of 4 mg/.kg/day treatment with methamphetamine fol lowed by
seven drug-free days.

Segawa and Urehara (1981) showed a decrease in

(3H)5-HT specific binding in rat whole brain preparations after four consecutive days of treatment with methiothepin and mianserin, two antidepressant drugs.

Leysen

et~

(1982) showed that mechanically-produced

cerebral lesions caused a significant decrease in binding sites for the
spiroperidol-sensitive receptor.

Research using the discussed methods

has yielded knowledge about the dysfunction of the 5·HT system induced
by toxic agents.

The data generated by Diaz and Huttenan (1972) and

Peters (1973, 1976) suggest that our experiments with LSD, utilizing the
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described doses (at least 10 times the LSD EDso) and the time periods of
treatment employed, would have been suitable for uncovering impairments
in the 5-HT system had they occurred.
Assuming a psychosis due to exposure to LSD does exist in humans,
the biochemical alterations accompanying it are not measurable given the
rat model which we utilized, the treatment conditions employed, and the
avail~ble

methodology.

It is the conclusion of this study that no evi-

dence was found to support the hypothesis that LSD produces long-lasting
alterations in the functioning of 5-HT neurons and that this is the
basis for LSD-induced psychosis.
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